Kenalog

Triamcinolone Acetonide, the active ingredient in Kenalog, is a glucocorticoid presented as an injectable solution for intravenous use. It exerts potent anti‑inflammatory and immunosuppressive effects and is employed in the management of severe allergic reactions, acute asthma exacerbations, and other systemic inflammatory conditions.

GNH USA supplies Kenalog as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support import and distribution across multiple jurisdictions.

Triamcinolone Acetonide is used intravenously to control severe inflammation and immune‑mediated disorders.

Severe allergic reactions: rapid reduction of airway edema and systemic hypersensitivity. Acute asthma exacerbations: suppression of bronchial inflammation to improve airflow. Rheumatoid arthritis flares: decrease joint swelling and pain during severe attacks. Systemic lupus erythematosus activity: control of multi‑organ inflammation when oral therapy is insufficient. Inflammatory bowel disease (severe): mitigation of intestinal inflammation in refractory cases.

Triamcinolone Acetonide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Increased blood glucose levels - Fluid retention and edema - Mood changes or insomnia - Gastrointestinal discomfort

Serious or Rare Side Effects: - Severe infection risk due to immunosuppression - Adrenal insufficiency on abrupt discontinuation - Osteonecrosis or severe bone loss

When using intravenous triamcinolone acetonide, clinicians should observe several safety measures.

- Assess infection risk: evaluate for active or latent infections before administration. - Monitor glucose: check blood sugar levels in diabetic patients during therapy. - Screen for osteoporosis: consider bone density assessment for long‑term use. - Taper after prolonged therapy: avoid abrupt cessation to prevent adrenal crisis. - Store at ambient temperature: keep in original container, protect from moisture and light.

Triamcinolone acetonide can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Live vaccines: concurrent use may cause uncontrolled infection. - CYP3A4 inhibitors (e.g., ketoconazole): can increase steroid exposure and toxicity.

Moderate Interactions (Monitor Closely): - Anticoagulants (warfarin): may enhance anticoagulant effect, monitor INR. - Diabetic agents: steroids may raise blood glucose, adjust dosage as needed. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): combined use raises risk of gastrointestinal ulceration.